RenovoRx, Inc. (RNXT)
USD 1.11
(-11.2%)
USD 1.11
(-11.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | - | 6000.00 | 9000.00 | - | - |
| Gross Profit | - | -6000.00 | -9000.00 | - | - |
| Operating Expenses | 11.39 Million | 9.95 Million | 5.67 Million | 3.2 Million | 3.89 Million |
| Selling, General and Administrative Expenses | 5.72 Million | 5.64 Million | 2.63 Million | 818 Thousand | 899 Thousand |
| Research and Development Expenses | 5.66 Million | 4.3 Million | 3.03 Million | 2.38 Million | 2.99 Million |
| Other Expenses | - | 61 Thousand | 119 Thousand | -7000.00 | 2000.00 |
| Cost and Expenses | 11.39 Million | 9.95 Million | 5.67 Million | 3.2 Million | 3.89 Million |
| Operating Income | -11.39 Million | -9.95 Million | -5.67 Million | -3.2 Million | -3.89 Million |
| Interest Expense | 108 Thousand | 57 Thousand | 834 Thousand | 590 Thousand | - |
| Income Tax Expense | - | -118 Thousand | 772 Thousand | 587 Thousand | -63 Thousand |
| Earnings before Tax | -10.23 Million | -9.88 Million | -6.32 Million | -3.79 Million | -3.83 Million |
| Net Income | -10.23 Million | -9.77 Million | -7.09 Million | -4.38 Million | -3.77 Million |
| Earnings Per Share Basic | -0.99 | -1.08 | -0.79 | -0.51 | -0.44 |
| Earnings Per Share Diluted | -0.99 | -1.08 | -0.79 | -0.51 | -0.44 |
| Weighted Average Shares Outstanding | 10.29 Million | 9.05 Million | 8.93 Million | 8.66 Million | 8.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.29 Million | 9.05 Million | 8.93 Million | 8.66 Million | 8.66 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -11.39 Million | -9.94 Million | -5.66 Million | - | - |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 3.03 Million | 2.47 Million | 1.77 Million | 11.39 Million | 2.98 Million | 3.37 Million |
| Selling, General and Administrative Expenses | 1.49 Million | 1.21 Million | 1 Million | - | 1.35 Million | 1.45 Million |
| Research and Development Expenses | 1.54 Million | 1.25 Million | 775 Thousand | - | 1.62 Million | 1.92 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 3.03 Million | 2.47 Million | 1.77 Million | 11.39 Million | 2.98 Million | 3.37 Million |
| Operating Income | -3.03 Million | -2.47 Million | -1.77 Million | -11.39 Million | -2.98 Million | -3.37 Million |
| Interest Expense | - | - | 112 Thousand | 108 Thousand | - | - |
| Income Tax Expense | -3.03 Million | -2.47 Million | 642 Thousand | -6.00 | -43 Thousand | -50 Thousand |
| Earnings before Tax | -2.38 Million | -1.07 Million | -3.22 Million | -10.23 Million | -1.42 Million | -2.32 Million |
| Net Income | -2.38 Million | -1.07 Million | -3.22 Million | -10.23 Million | -1.42 Million | -2.32 Million |
| Earnings Per Share Basic | -0.10 | -0.07 | -0.30 | - | -0.13 | -0.22 |
| Earnings Per Share Diluted | -0.10 | -0.07 | -0.30 | - | -0.13 | -0.22 |
| Weighted Average Shares Outstanding | 24.04 Million | 14.94 Million | 10.69 Million | 10.29 Million | 10.69 Million | 10.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 24.04 Million | 14.94 Million | 10.69 Million | 10.29 Million | 10.69 Million | 10.65 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -3.03 Million | -2.47 Million | -969 Thousand | - | -4.5 Million | -4.37 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
IVZ
CCZ
WEGYF
TLDE
0TMV
IMM